Evolution in Reimbursement for Sleep Studies and Sleep Centers

Parish, James M.; Freedman, Neil; Manaker, Scott

doi:10.1378/chest.14-1648

Cited by 15 publications

(5 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As a result, few people seek medical assistance, health professionals often provide significant under-treatment, and many insurance plans do not cover either testing or treatment of this condition. 2,[11][12][13] Although the preferred method of treatment of sleep disorders is cognitive behavioral therapy, sleeplessness is most commonly treated with medications, either by medical professionals or via self-medication. 2,4,12 The ideal substance to be taken to resolve occasional sleeplessness would have the following characteristics: can be administered orally, induces sleep rapidly, maintains sleep for between seven and nine hours, induces restorative sleep, is not habit forming, and has a low risk of overdose leading to death.…”

Section: Nonrestorative Sleep (Nrs): Feeling Unrefreshed Upon Awakeningmentioning

confidence: 99%

Use of a water-soluble form of cannabinol for the treatment of sleeplessness

Kaufmann¹

2021

IJCAM

View full text Add to dashboard Cite

Introduction: Sleeplessness, i.e., getting <7hours sleep/night (L7H), causes significant health and financial problems for individuals and industry. Sleeplessness is classified into 4 categories: difficulty initiating sleep (DIS), difficulty maintaining sleep (DMS), early morning awakening (EMA), and nonrestorative sleep (NRS). This study surveyed individuals with sleeplessness who were taking a water-soluble product of cannabinol (CBN) treated using nano technology, which has recently become available.Methods: Individuals taking this product completed a self-evaluation survey prior to and after taking this product for at least 7days. The data was analyzed for changes in rate and severity of sleeplessness. Severity was assessed by the number of days/week for all categories except NRS, which had a symptom score with the range: -6 to +6. Significance was p < 0.001. Results:Sixty individuals returned the survey. For all sleep disorder categories, using this product significantly decreased incidence (L7S: 42% to 13%, DIS: 42% to 2%, DMS: 57% to 22%, EMA: 42% to 13%, NRS: 60% to 13%) and severity (L7S: 5.72+1.46 to 1.88 + 2.80, DIS: 4.77+2.12 to 0.38+1.27, DMS: 5.00+1.89 to 2.21+2.91, EMA: 4.96+1.82 to 1.7+2.76, NRS: -1.43+3.03 to 2.85+2.16). Thirteen individuals had an adverse side effect that resolved in all individuals after self-adjustment of the dose. Conclusions:This nano treated CBN product rapidly induced sleep initially and after awakening, increasing the time and quality of sleep in most individuals suffering from sleeplessness.

show abstract

Section: Nonrestorative Sleep (Nrs): Feeling Unrefreshed Upon Awakeningmentioning

confidence: 99%

Use of a water-soluble form of cannabinol for the treatment of sleeplessness

Kaufmann¹

2021

IJCAM

View full text Add to dashboard Cite

show abstract

“…In the U.S., in 2011 alone, Medicare received more than 1 million polysomnogram (PSG) claims and reimbursed $US 565 million for PSG. Over 6 years from 2005 to 2011, Medicare payments for PSG increased by 39% . Considering the advent of emerging monitoring technologies and the introduction of wireless connectivity into patients’ homes, the potential for remote telemonitoring (TM) to change and restructure current care management paradigms is immense.…”

Section: Introductionmentioning

confidence: 99%

Does remote monitoring change OSA management and CPAP adherence?

et al. 2017

View full text Add to dashboard Cite

It is increasingly recognized that the high prevalence of obstructive sleep apnoea (OSA), and its associated cardio-metabolic morbidities make OSA a burden for society. Continuous positive airway pressure (CPAP), the gold standard treatment, needs to be used for more than 4 h/night to be effective, but suffers from relatively poor adherence. Furthermore, CPAP is likely to be more effective if combined with lifestyle changes. Thus, the remote telemonitoring (TM) of OSA patients in terms of CPAP use, signalling of device problems, following disease progression, detection of acute events and monitoring of daily physical activity is an attractive option. In the present review, we aim to summarize the recent scientific data on remote TM of OSA patients, and whether it meets expectations. We also look at how patient education and follow-up via telemedicine is used to improve adherence and we discuss the influence of the profile of the healthcare provider. Then, we consider how TM might be extended to encompass the patient's cardio-metabolic health in general. Lastly, we explore how TM and the deluge of data it potentially generates could be combined with electronic health records in providing personalized care and multi-disease management to OSA patients.

show abstract

“…Changes in technology and reductions in reimbursement for sleep-related services have limited this option, however. [17][18][19] In addition, the option for the latercareer physician to transition into an administrative role has become more difficult as the skill set required to navigate the evolving health-care environment has become more complicated. Thus, many physicians, regardless of their current employment model, will be faced with difficult choices as the pressures of practicing medicine continue to evolve.…”

Section: Limitations On Typical Practice Options For Later-career Pulmentioning

confidence: 99%

POINT: Is It Time for Pulmonary Concierge Practices? Yes

Freedman

2017

Chest

View full text Add to dashboard Cite

Evolution in Reimbursement for Sleep Studies and Sleep Centers

Cited by 15 publications

References 14 publications

Use of a water-soluble form of cannabinol for the treatment of sleeplessness

Use of a water-soluble form of cannabinol for the treatment of sleeplessness

Does remote monitoring change OSA management and CPAP adherence?

POINT: Is It Time for Pulmonary Concierge Practices? Yes

Contact Info

Product

Resources

About